AJANTA PHARMA
Back to Income Statement
|
AJANTA PHARMA Last 5 Year Total Expenditure History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹3,037 Cr | ₹2,959 Cr | ₹2,412 Cr | ₹1,891 Cr | ₹1,905 Cr |
What is the latest Total Expenditure of AJANTA PHARMA ?
| Year | Total Expenditure |
|---|---|
| Mar2025 | ₹3,037 Cr |
| Mar2024 | ₹2,959 Cr |
| Mar2023 | ₹2,412 Cr |
| Mar2022 | ₹1,891 Cr |
| Mar2021 | ₹1,905 Cr |
How is Total Expenditure of AJANTA PHARMA Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2025 | ₹3,037 Cr | 2.61 | |
| Mar2024 | ₹2,959 Cr | 22.71 | |
| Mar2023 | ₹2,412 Cr | 27.53 | |
| Mar2022 | ₹1,891 Cr | -0.70 | |
| Mar2021 | ₹1,905 Cr | - | |
Compare Total Expenditure of peers of AJANTA PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AJANTA PHARMA | ₹37,151.5 Cr | -3.5% | 4.6% | 14.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,777.0 Cr | -0.8% | 7.4% | 8.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,931.0 Cr | -1.5% | 5.7% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,330.0 Cr | -1.8% | 8.8% | 44.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,593.0 Cr | -1.2% | 9.2% | 14.9% | Stock Analytics | |
| CIPLA | ₹107,112.0 Cr | -2.5% | 0.1% | -7.6% | Stock Analytics | |
AJANTA PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AJANTA PHARMA | -3.5% |
4.6% |
14.3% |
| SENSEX | -3.8% |
-2% |
6.3% |
You may also like the below Video Courses